Press Release: Glucose Health, Inc. Reports Fiscal 2021 YTD Revenue Up 123% and New Amazon Sales Record
Press Release: Glucose Health, Inc. Reports Fiscal 2021 YTD Revenue Up 123% and New Amazon Sales Record
Press Release: Glucose Health, Inc. Reports Fiscal 2021 YTD Revenue Up 123% and New Amazon Sales Record
新聞稿：葡萄糖健康公司報告2021財年收入增長123%，亞馬遜銷售額創歷史新高
Glucose Health, Inc. Reports Fiscal 2021 YTD Revenue Up 123% and New Amazon Sales Record
葡萄糖健康公司報告2021財年收入增長123%，亞馬遜銷售額創歷史新高
PR Newswire
美通社
BENTONVILLE, Ark., Aug. 9, 2021
阿肯色州本頓維爾，2021年8月9日
BENTONVILLE, Ark., Aug. 9, 2021 /PRNewswire/ -- Glucose Health, Inc. (OTC: GLUC) ("Company") is pleased to highlight key financial information detailed in its June 30, 2021 Quarterly Report, posted this morning at OTCMarkets.com.
亞洲網阿肯色州本頓維爾2021年8月9日電葡萄糖健康公司(場外交易代碼：GLUC)(簡稱“公司”)高興地強調其2021年6月30日季度報告中詳細介紹的重要財務信息，該報告今天上午在場外交易市場(OTCMarkets.com)公佈。
-- YTD Fiscal 2021 Revenue of $524,568 vs. $234,752 for YTD Fiscal 2020 -- an increase of 123% -- Q2 Fiscal 2021 Revenue of $287,103 vs. $151,139 for Q2 Fiscal 2020 -- an increase of 89% -- YTD Fiscal 2021 Gross Profit of $217,794 vs. $96,886 for YTD Fiscal 2020 -- an increase of 125% -- Q2 Fiscal 2021 Gross Profit of $102,923 vs. $69,906 for YTD Fiscal 2020 -- an increase of 47%
--2021年第二季度收入為287,103美元，2020財年第二季度為151,139美元，增長89%--2021財年第二季度毛利潤為217,794美元，2020財年為96,886美元--增長125%--2021財年第二季度收入為287,103美元，2020財年為151,139美元，同比增長125%--2020財年第二季度毛利潤為217,794美元，2020財年為96,886美元，同比增長123%--2021財年第二季度收入為287,103美元，2020財年第二季度為151,139美元，同比增長89%--2020財年第二季度毛利潤為217,794美元，2020財年為96,886美元
GLUCODOWN(R) sales at Amazon for April 2021, the first month of Q2, reached a new monthly record of $74,944, beating the previous monthly sales record of $38,595 announced by the Company for June 2020, by 94%.
2021年4月，也就是第二季度的第一個月，GLUCODOWN(R)在亞馬遜的銷售額創下了74944美元的月度新紀錄，打破了該公司此前宣佈的2020年6月38595美元的月度銷售額紀錄，增長了94%。
Important: Additional GLUC news updatesto be released in the next two weeks.
重要提示：GLUC的其他新聞更新將在接下來的兩週內發佈。
GLUC will update shareholders regarding the reduction of its fully-diluted share count by one-third.
GLUC將向股東通報其完全稀釋後的股份數量減少三分之一的最新情況。
GLUC will update shareholders regarding the reduction of its outstanding debt and liabilities to zero.
GLUC將向股東通報將其未償債務和負債降至零的最新情況。
About Glucose Health, Inc. (OTC: GLUC)
葡萄糖健康公司簡介(場外交易代碼：GLUC)
With a focus on creating delicious beverages nutritionally appropriate(1) for the nation's 100+ million(2) pre and Type-2 diabetics, Glucose Health, Inc., the manufacturer of GLUCODOWN(R), is uniquely positioned among all emerging beverage companies in America. Introduced in the third quarter of 2018, the GLUCODOWN(R) brand has established itself as the market leader for an entirely new category -- functional, diabetic friendly, beverages. Glucose Health, Inc. is a publicly traded company with the ticker symbol OTC: GLUC.
GLUCODOWN(註冊商標)的製造商葡萄糖健康公司致力於為全美1億多(2)糖尿病前期和2型糖尿病患者(1)創造營養適中的美味飲料，在美國所有新興飲料公司中處於獨特的地位。在美國，GLUCODOWN(R)的製造商GLUCODOWN(R)的製造商GLUCODOWN(R)在美國所有新興飲料公司中處於獨特的地位。於2018年第三季度推出的GLUCODOWN(R)品牌已經確立了自己作為一個全新類別--功能性、糖尿病友好型飲料--市場領導者的地位。葡萄糖健康公司是一家上市公司，股票代碼為OTC：GLUC。
To buy GLUCODOWN(R) visit our Amazon Store at www.amazon.com/glucodown
要購買GLUCODOWN(R)，請訪問我們的亞馬遜商店：www.amazon.com/graodown
Like us on Facebook at www.facebook.com/glucodown
在Facebook上點讚我們，網址為www.facebook.com/glodown
For more GLUC information visit www.glucosehealthinc.com
欲獲知更多有關GLUC的信息，請訪問網址：www.graoseHealth sinc.com。
(1) For citations visit www.glucodown.com/clinical-data
(1)有關引用，請訪問www.graodown.com/clinic-data
(2) National Diabetes Statistics Review, 2020; Centers for Disease Control and Prevention, Department of Health and Human Services
(2)《2020年國家糖尿病統計評論》；衞生與公眾服務部疾病控制與預防中心
This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and while Glucose Health, Inc. is not subject to the 1934 Securities and Exchange Act, contains forward-looking statements within the meaning Section 21E of the Securities and Exchange Act of 1934, as amended. Statements that are not a description of historical facts constitute forward-looking statements and may often, but not always, be identified by the use of such words as "expects," "anticipates," "intends," "estimates," "plans," "potential, "possible," "probable, "believes," "seeks," "may, "will, "should," "could" or the negative of such terms or other similar expressions. Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in the Company's business. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and the Company undertakes no obligation to revise or update this release to reflect events or circumstances after the date hereof.
本新聞稿包含符合1933年“證券法”(經修訂)第27A條的前瞻性陳述，雖然葡萄糖健康公司不受1934年“證券交易法”的約束，但含有符合1934年“證券交易法”第21E條(經修訂)的前瞻性陳述。不描述歷史事實的陳述構成前瞻性陳述，經常但並非總是通過使用“預期”、“預期”、“打算”、“估計”、“計劃”、“可能”、“相信”、“尋求”、“可能”、“將會”、“應該”、“可能”或此類術語的否定或其他類似表述來識別。由於公司業務固有的風險和不確定性，實際結果可能與本新聞稿中陳述的大不相同。告誡讀者不要過度依賴這些前瞻性陳述，這些陳述僅説明截至本文發佈之日的情況。所有前瞻性陳述都完全受本警告性聲明的限制，公司沒有義務修改或更新本新聞稿，以反映此後發生的事件或情況。
Contact:
聯繫方式：
Murray Fleming
默裏·弗萊明
Glucose Health, Inc.
葡萄糖健康公司
info@glucosehealthinc.com
電子郵箱：info@graoseHealth Thinc.com
(479) 802-3827
(479) 802-3827
View original content to download multimedia:https://www.prnewswire.com/news-releases/glucose-health-inc-reports-fiscal-2021-ytd-revenue-up-123-and-new-amazon-sales-record-301350822.html
查看原創內容以下載multimedia:https://www.prnewswire.com/news-releases/glucose-health-inc-reports-fiscal-2021-ytd-revenue-up-123-and-new-amazon-sales-record-301350822.html
SOURCE Glucose Health, Inc.
來源：葡萄糖健康公司
(END) Dow Jones Newswires
(完)道瓊通訊社
August 09, 2021 06:30 ET (10:30 GMT)
美國東部時間2021年8月09日06：30(格林尼治標準時間10：30)
譯文內容由第三人軟體翻譯。